---
document_datetime: 2023-09-21 19:47:08
document_pages: 3
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/taxespira-previously-docetaxel-hospira-uk-limited-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
document_name: taxespira-previously-docetaxel-hospira-uk-limited-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 1.9850614
conversion_datetime: 2025-12-28 15:47:16.161583
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Taxespira

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                                                                                                        | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on product   | Product Information affected 3   | Summary   |
|----------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|-----------------------------------------------------|----------------------------------|-----------|
| IB/0011              | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH | 09/07/2018                          |                                                     | SmPC and PL                      |           |
| IB/0010/G            | This was an application for a group of variations.                                                                                                                                                                                                           | 12/01/2018                          | 19/07/2018                                          | SmPC and PL                      |           |

<!-- image -->

Medicinal product no longer auth

<!-- image -->

<div style=\"page-break-after: always\"></div>

<!-- image -->

|         | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH   |                    | no longer                   |     |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------|-----------------------------|-----|
| N/0009  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                            | 16/11/2017         | 19/07/2018 PL               |     |
| IB/0008 | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the                                                                                                                                                                                                                                                                    | 01/08/2017 product | 19/07/2018 SmPC and PL      | MAH |
| N/0007  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                            | 16/02/2017         | 19/07/2018 Labelling and PL |     |
| N/0006  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                            | 17/06/2016         | PL                          |     |
| IG/0693 | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site Medicinal                                                                                                                                                                                                                                                                                                                                                                                                                | 02/06/2016         | 11/11/2016 n/a              |     |

<div style=\"page-break-after: always\"></div>

| II/0003     | B.II.e.5.c - Change in pack size of the finished product - Change in the fill weight/fill volume of sterile multidose (or single-dose, partial use) parenteral medicinal products, including biological/immunological medicinal products                                                                                                                                                                                                                                       | 17/03/2016         | 11/11/2016   | SmPC, Labelling and PL auth      |
|-------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------|--------------|----------------------------------|
| IB/0004     | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                                                                                   | 28/01/2016         | 11/11/2016   | SmPC, Labelling and PL longer    |
| IG/0645     | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location                                                                                                                                                                                                                                                                                                                | 17/12/2015         | n/a no       |                                  |
| IAIN/0001/G | This was an application for a group of variations. A.1 - Administrative change - Change in the name and/or address of the MAH A.2.a - Administrative change - Change in the (invented) name of the medicinal product for CAPs B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing Medicinal | 13/11/2015 product | 11/11/2016   | SmPC, Annex II, Labelling and PL |